CYTX

Cytori Therapeutics Inc Press Releases

$0.4789
*  
0.0009
0.19%
Get CYTX Alerts
*Delayed - data as of Jan. 23, 2015  -  Find a broker to begin trading CYTX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Cytori and Leading Expert Discuss Importance of ‘STAR’ Trial and Treatment for Scleroderma Patients
1/20/2015 4:15:00 PM - Business Wire
▲1.89 % Price Change since this news event. The Volume Ratio is 0.58.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


FDA Approves Cytori U.S. Pivotal Scleroderma Trial
1/12/2015 8:00:00 AM - Business Wire
▼-6.10 % Price Change since this news event. The Volume Ratio is 1.41.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Cytori and BARDA Amend Contract Option to Accelerate the Advancement of a Thermal Burn Injury Countermeasure
12/19/2014 8:00:00 AM - Business Wire
▼-6.10 % Price Change since this news event. The Volume Ratio is 1.15.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Cytori to Host an Informational Session on Its Planned U.S. STAR Pivotal Trial With Principal Investigator, Dr. Dinesh Khanna
12/18/2014 5:39:00 PM - Business Wire


Cytori to Host an Informational Session on Its Planned U.S. STAR Pivotal Trial With Principal Investigator, Dr. Dinesh Khanna
12/18/2014 5:39:00 PM - Business Wire
▼-6.10 % Price Change since this news event. The Volume Ratio is 1.15.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Cytori to Provide Corporate Update at 2015 Biotech Showcase™ in San Francisco
12/17/2014 7:25:00 PM - Business Wire
▼-2.27 % Price Change since this news event. The Volume Ratio is 0.97.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


FDA Grants Cytori Conditional Approval for a U.S. Pivotal Clinical Trial in Scleroderma
12/10/2014 8:00:00 AM - Business Wire
▲4.11 % Price Change since this news event. The Volume Ratio is 8.24.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Cytori Therapeutics'' Investor Presentation Now Available for On-Demand Viewing
12/5/2014 8:00:00 AM - PR Newswire


Cytori Therapeutics' Investor Presentation Now Available for On-Demand Viewing
12/5/2014 8:00:00 AM - PR Newswire
▲4.11 % Price Change since this news event. The Volume Ratio is 1.98.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Cytori Expects New Japan Laws to Boost Adoption of Cytori Cell Therapy
12/4/2014 8:00:00 AM - Business Wire
▲14.02 % Price Change since this news event. The Volume Ratio is 1.52.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Eight Companies Webcast Live to Investors, December 4th at VirtualInvestorConferences.com
12/2/2014 8:29:00 AM - PR Newswire


Cytori Announces Promising Results in a Feasibility Trial of Cytori Cell Therapy in Conjunction with Anterior Cruciate Ligament Repair
11/21/2014 8:00:00 AM - Business Wire


Cytori Therapeutics to Provide Corporate Update and Investor Presentation on December 4 through a Live, Interactive Webcast
11/20/2014 4:09:00 PM - PR Newswire


Safety and Feasibility of Cytori Cell Therapy in Acute Myocardial Infarction Presented at 2014 American Heart Association Meeting
11/18/2014 11:00:00 AM - Business Wire


Cytori Reports Third Quarter 2014 Business and Financial Results
11/6/2014 4:05:00 PM - Business Wire
▼-4.22 % Price Change since this news event. The Volume Ratio is 2.06.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day